Mutational landscape of homologous recombination‐related genes in small‐cell lung cancer

Abstract Background Homologous recombination deficiency (HRD) is a well‐known biomarker which could predict poly‐ADP ribose polymerase 1 (PARP) inhibitor and platinum drug response. As an aggressive cancer, small‐cell lung cancer (SCLC) is sensitive to platinum drugs, but relapse occurs rapidly. Her...

Full description

Bibliographic Details
Main Authors: Shuo Wu, Yao Zhang, Yan Zhang, Liz‐han Chen, Hai‐feng Ouyang, Xi Xu, Ying Du, Xin‐yu Ti
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.5148